Skip to content

BT-LIFE: Brain tumours, lifestyle interventions and fatigue evaluation

Brain tumours, lifestyle interventions and fatigue evaluation: a multi-centre feasibility randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17883425
Enrollment
60
Registered
2018-10-02
Start date
2018-10-15
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue in people with brain cancer Cancer

Interventions

Patients will be randomised to one of the three study arms through minimisation to ensure balance, with the minimisation factor being recruiting site. Group 1: This is

Sponsors

NHS Lothian
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 and above 2. Diagnosed with any primary brain tumour 3. >3 months post-completion of chemotherapy/radiotherapy 4. Clinically and radiologically stable, as defined by no evidence of disease progression at most recent clinic appointment 5. Moderate or severe fatigue (Brief Fatigue Inventory score =4/10, indicating at least ‘moderate’ severity of fatigue over the previous week) 6. Participants can be male or female

Exclusion criteria

Exclusion criteria: 1. Patients unable to give informed consent, or are unable or unwilling to comply with interventions 2. Patients with significant cognitive or sensory impairment (e.g. severe dysphasia or severe visual impairment) 3. Patients who are clinically unstable 4. Radiological or clinical concern at most recent appointment over disease progression

Design outcomes

Primary

MeasureTime frame
The feasibility of delivering Health Coaching and Patient Activation to fatigued patients with a primary brain tumour. Feasibility will be assessed by meeting a priori defined standards for recruitment and retention as follows: 1. Recruitment will be feasible if 20 fatigued brain tumour patients can be recruited per centre over 12 months 2. Retention will be feasible if total attrition at T2 (endpoint) is less than or equal to 40%

Secondary

MeasureTime frame
1. The acceptability of the interventions to patients 2. The manageability of the interventions for professionals 3. The development of systems and piloting outcome measures for future definitive RCTs of the interventions for fatigued brain tumour patients, including determination of mean change in outcome scale scores in each arm

Countries

England, Scotland, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026